These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


460 related items for PubMed ID: 9495517

  • 1. Intestinal calcium absorption and bone metabolism in young adult men with childhood-onset growth hormone deficiency.
    de Boer H, Blok GJ, Popp-Snijders C, Sips A, Lips P, van der Veen E.
    J Bone Miner Res; 1998 Feb; 13(2):245-52. PubMed ID: 9495517
    [Abstract] [Full Text] [Related]

  • 2. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R, Mattsson AF, Bengtsson BA, Feldt-Rasmussen U, Góth MI, Koltowska-Häggström M, Monson JP, Verhelst J, Wilton P, KIMS Study Group.
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [Abstract] [Full Text] [Related]

  • 3. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
    Gonc EN, Kandemir N.
    Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
    [Abstract] [Full Text] [Related]

  • 4. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
    Wilhelm B, Kann PH.
    Med Klin (Munich); 2004 Oct 15; 99(10):569-77. PubMed ID: 15490072
    [Abstract] [Full Text] [Related]

  • 5. [Effect of GH/IGF-I deficiency on bone and collagen turnover in children and adults with GH deficiency].
    Sartorio A, Conti A, Monzani M, Ferrero S, Biella O, Casati G, Faglia G.
    Minerva Endocrinol; 1995 Jun 15; 20(2):135-40. PubMed ID: 8531895
    [Abstract] [Full Text] [Related]

  • 6. Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency.
    Magnusson P, Degerblad M, Sääf M, Larsson L, Thorén M.
    J Bone Miner Res; 1997 Feb 15; 12(2):210-20. PubMed ID: 9041052
    [Abstract] [Full Text] [Related]

  • 7. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH, Huang TS, Hsieh SJ.
    Miner Electrolyte Metab; 1996 Feb 15; 22(4):219-23. PubMed ID: 8807625
    [Abstract] [Full Text] [Related]

  • 8. How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy.
    Cortet B, Flipo RM, Pigny P, Duquesnoy B, Racadot A, Boersma A, Delcambre B.
    Rev Rhum Engl Ed; 1997 Mar 15; 64(3):153-9. PubMed ID: 9090763
    [Abstract] [Full Text] [Related]

  • 9. Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency.
    Bollerslev J, Møller J, Thomas S, Djøseland O, Christiansen JS.
    Eur J Endocrinol; 1996 Dec 15; 135(6):666-71. PubMed ID: 9025710
    [Abstract] [Full Text] [Related]

  • 10. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
    Joseph F, Ahmad AM, Ul-Haq M, Durham BH, Whittingham P, Fraser WD, Vora JP.
    J Bone Miner Res; 2008 May 15; 23(5):721-9. PubMed ID: 18052753
    [Abstract] [Full Text] [Related]

  • 11. Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis.
    Kassem M, Brixen K, Blum WF, Mosekilde L, Eriksen EF.
    J Bone Miner Res; 1994 Sep 15; 9(9):1365-70. PubMed ID: 7817819
    [Abstract] [Full Text] [Related]

  • 12. [Growth hormone deficiency, its influence on bone mineral density and risk of osteoporotic fractures].
    Kuzma M, Payer J.
    Cas Lek Cesk; 2010 Sep 15; 149(5):211-6. PubMed ID: 20629339
    [Abstract] [Full Text] [Related]

  • 13. Treatment with the oral growth hormone secretagogue MK-677 increases markers of bone formation and bone resorption in obese young males.
    Svensson J, Ohlsson C, Jansson JO, Murphy G, Wyss D, Krupa D, Cerchio K, Polvino W, Gertz B, Baylink D, Mohan S, Bengtsson BA.
    J Bone Miner Res; 1998 Jul 15; 13(7):1158-66. PubMed ID: 9661080
    [Abstract] [Full Text] [Related]

  • 14. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
    Lagrou K, Xhrouet-Heinrichs D, Massa G, Vandeweghe M, Bourguignon JP, De Schepper J, de Zegher F, Ernould C, Heinrichs C, Malvaux P, Craen M.
    J Pediatr Endocrinol Metab; 2001 Jul 15; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
    [Abstract] [Full Text] [Related]

  • 15. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
    Amin S, Riggs BL, Melton LJ, Achenbach SJ, Atkinson EJ, Khosla S.
    J Bone Miner Res; 2007 Jun 15; 22(6):799-807. PubMed ID: 17352648
    [Abstract] [Full Text] [Related]

  • 16. Evidence for an acute rise of intestinal calcium absorption in response to aerobic exercise.
    Zittermann A, Sabatschus O, Jantzen S, Platen P, Danz A, Stehle P.
    Eur J Nutr; 2002 Oct 15; 41(5):189-96. PubMed ID: 12395212
    [Abstract] [Full Text] [Related]

  • 17. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.
    Välimäki MJ, Tiihonen M, Laitinen K, Tähtelä R, Kärkkäinen M, Lamberg-Allardt C, Mäkelä P, Tunninen R.
    J Bone Miner Res; 1994 May 15; 9(5):631-7. PubMed ID: 8053391
    [Abstract] [Full Text] [Related]

  • 18. Gender variation in PTH sensitivity and rhythmicity following growth hormone replacement in adult growth hormone-deficient patients.
    White HD, Ahmad AM, Syed AA, Clewes A, Peter R, Vora JP, Fraser WD.
    Clin Endocrinol (Oxf); 2004 Apr 15; 60(4):516-26. PubMed ID: 15049968
    [Abstract] [Full Text] [Related]

  • 19. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
    Thorén M, Hilding A, Brismar T, Magnusson P, Degerblad M, Larsson L, Sääf M, Baylink DJ, Mohan S.
    J Bone Miner Res; 1998 May 15; 13(5):891-9. PubMed ID: 9610754
    [Abstract] [Full Text] [Related]

  • 20. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry.
    Eriksen EF, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J.
    J Bone Miner Res; 1993 Feb 15; 8(2):127-32. PubMed ID: 8442431
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.